Skip to main content
Spryson logo

Spryson

Toronto, Ontario, CanadaSee on the mapFounded 2019

Spryson develops eye-tracking and vestibular assessment systems that help clinicians and researchers objectively measure brain, balance, and eye-movement function. Its FDA-cleared products and software are used by more than 350 clinical and research organizations.

Raised
$1.2M
Investor
1
Founded
2019
Employees
11–50

reccy insights

Recent highlights

Spryson's available company milestones center on its diagnostic platform rather than a dated sequence of announcements. The company develops eye-tracking and vestibular assessment systems for measuring brain, balance, and eye-movement function. Its product portfolio combines goggles, a motorized rotational chair, and clinical software, and its technology has five FDA 510(k) clearances. Spryson reports more than 400,000 tests conducted across over 350 clinical and research organizations, indicating use beyond a single specialty or research setting. The company also describes normative comparisons and longitudinal tracking to support interpretation of results over time. A dated financial milestone is a $753,267 grant recorded on Apr 1, 2019, with HHS named as lead investor. Together, these facts point to a focus on objective measurement and repeatability in clinical and research workflows.

Written by reccy's AI from company sites, press and funding records · updated Nov 2026

What makes Spryson distinct

  1. 01Combines eye-tracking and vestibular assessment across goggles, a rotational chair, and clinical software.
  2. 02Has five FDA 510(k) clearances and supports objective, repeatable assessment.
  3. 03Reports more than 400,000 tests across over 350 clinical and research organizations.
  4. 04Provides normative reference comparisons and longitudinal tracking to help interpret results over time.
  5. 05Serves clinical and research settings including neurology, vestibular care, concussion assessment, rehabilitation, and clinical trials.

Technology & products4

  • DX200

    Eye-tracking goggles with oculomotor, vestibular, reaction-time, and cognitive testing.

  • NOTC Pro+

    Motorized rotational chair for vestibular assessment.

  • Falcon vHIT

    Video goggles for head-impulse and positional testing.

Funding

$1.2M disclosed
  • Grant (prize money)Apr 2019
    $753KLed by HHS
1 investor

Investors1

On reccy

About Spryson

Products
DX200, NOTC Pro+, Falcon vHIT, Clinical software
Leadership
Claudia DovaliPrateek DwivediRob Adelson
Focus areas
Medical devices, digital health, eye tracking, vestibular assessment, clinical diagnostics, neurology, clinical research, healthcare technology
Headquarters
Toronto, Ontario, Canada
Founded
2019
Employees
11–50